America's first
exclusively orphanAmerica's first
exclusively orphanWe have helped bring life-saving and life-extending treatments to people with unmet medical needs for over 30 years.
As America’s first exclusively orphan drug company, we have expertise in regulatory affairs, sales and marketing, and medical affairs – with a proven track record of success in bringing orphan drugs through the FDA approval process.
RDT isn’t “Big Pharma.” We are a privately held, specialized company that moves quickly and efficiently to meet patient needs. We have pride in our skill and efficiency in bringing orphan drugs to market:
See our current portfolio of rare disease treatments alongside our pipeline of future offerings
* IND = Investigational New Drug Application, BLA = Biologics License Application, NDA = New Drug Application